iCCC diagnostic criteria are: (a) composite CCC with conventional adenocarcinoma or presence of adenomatous component [75], (b) absence of adjacent endometriosis, (c) intestinal immunoprofile (CK20+, CK7−, CEA+, CDX-2+) [74,76]. The gene discussed is CDX2; the disease is adenocarcinoma.